Regulation of vascular endothelial growth factor binding and activity by extracellular pH

被引:56
作者
Goerges, AL [1 ]
Nugent, MA [1 ]
机构
[1] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA
关键词
D O I
10.1074/jbc.M211208200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Angiogenesis, the growth of new blood vessels, is regulated by a number of factors, including hypoxia and vascular endothelial growth factor ( VEGF). Although the effects of hypoxia have been studied intensely, less attention has been given to other extracellular parameters such as pH. Thus, the present study investigates the consequences of acidic pH on VEGF binding and activity in endothelial cell cultures. We found that the binding of VEGF(165) and VEGF(121) to endothelial cells increased as the extracellular pH was decreased from 7.5 to 5.5. Binding of VEGF(165) and VEGF(121) to endothelial extracellular matrix was also increased at acidic pH. These effects were, in part, a reflection of increased heparin binding, because VEGF(165) and VEGF(121) showed increased retention on heparin-Sepharose at pH 5.5 compared with pH 7.5. Consistent with these findings, soluble heparin competed for VEGF binding to endothelial cells under acidic conditions. However, at neutral pH ( 7.5) low concentrations of heparin (0.1-1.0 mug/ml) potentiated VEGF binding. Extracellular pH also regulated VEGF activation of the extracellular signal-regulated kinases 1 and 2 (Erk1/2). VEGF(165) and VEGF(121) activation of Erk1/ 2 at pH 7.5 peaked after 5 min, whereas at pH 6.5 the peak was shifted to 10 min. At pH 5.5, neither VEGF isoform was able to activate Erk1/ 2, suggesting that the increased VEGF bound to the cells at low pH was sequestered in a stored state. Therefore, extracellular pH might play an important role in regulating VEGF interactions with cells and the extracellular matrix, which can modulate VEGF activity.
引用
收藏
页码:19518 / 19525
页数:8
相关论文
共 41 条
  • [1] Microvessel formation from mouse embryonic aortic explants is oxygen and VEGF dependent
    Akimoto, T
    Liapis, H
    Hammerman, MR
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2002, 283 (02) : R487 - R495
  • [2] BASIC FIBROBLAST GROWTH-FACTOR BINDS TO SUBENDOTHELIAL EXTRACELLULAR-MATRIX AND IS RELEASED BY HEPARITINASE AND HEPARIN-LIKE MOLECULES
    BASHKIN, P
    DOCTROW, S
    KLAGSBRUN, M
    SVAHN, CM
    FOLKMAN, J
    VLODAVSKY, I
    [J]. BIOCHEMISTRY, 1989, 28 (04) : 1737 - 1743
  • [3] Functions of cell surface heparan sulfate proteoglycans
    Bernfield, M
    Götte, M
    Park, PW
    Reizes, O
    Fitzgerald, ML
    Lincecum, J
    Zako, M
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 : 729 - 777
  • [4] Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression
    Brogi, E
    Schatteman, G
    Wu, T
    Kim, EA
    Varticovski, L
    Keyt, B
    Isner, JM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (02) : 469 - 476
  • [5] The effect of extracellular pH on angiogenesis in vitro
    Burbridge M.F.
    West D.C.
    Atassi G.
    Tucker G.C.
    [J]. Angiogenesis, 1999, 3 (3) : 281 - 288
  • [6] Acidosis inhibits endothelial cell apoptosis and function and induces basic fibroblast growth factor and vascular endothelial growth factor expression
    D'Arcangelo, D
    Facchiano, F
    Barlucchi, LM
    Melillo, G
    Illi, B
    Testolin, L
    Gaetano, C
    Capogrossi, MC
    [J]. CIRCULATION RESEARCH, 2000, 86 (03) : 312 - 318
  • [7] ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASES BY VASCULAR ENDOTHELIAL GROWTH-FACTOR AND BASIC FIBROBLAST GROWTH-FACTOR IN CAPILLARY ENDOTHELIAL-CELLS IS INHIBITED BY THE ANTIANGIOGENIC FACTOR 16-KDA N-TERMINAL FRAGMENT OF PROLACTIN
    DANGELO, G
    STRUMAN, I
    MARTIAL, J
    WEINER, RI
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (14) : 6374 - 6378
  • [8] Molecular diversity of heparan sulfate
    Esko, JD
    Lindahl, U
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (02) : 169 - 173
  • [9] Potentiation and inhibition of bFGF binding by heparin: A model for regulation of cellular response
    Fannon, M
    Forsten, KE
    Nugent, MA
    [J]. BIOCHEMISTRY, 2000, 39 (06) : 1434 - 1445
  • [10] ANGIOGENESIS IN CANCER, VASCULAR, RHEUMATOID AND OTHER DISEASE
    FOLKMAN, J
    [J]. NATURE MEDICINE, 1995, 1 (01) : 27 - 31